DRG Epidemiology’s coverage of myelodysplastic syndromes comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of…
MARKET OVERVIEWPrimary membranous nephropathy (PMN) is a kidney-specific, progressive, autoimmune disease primarily characterized by high proteinuria. Based on multiple clinical factors, such as…
DRG Epidemiology’s coverage of myelodysplastic syndromes comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of…
DRG Epidemiology’s coverage of myelodysplastic syndromes comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of…
DRG Epidemiology’s coverage of endometrial cancer comprises epidemiological estimates of key patient populations in the Middle East and Africa (Egypt, Nigeria, Saudi Arabia, and South Africa). We…
DRG Epidemiology’s coverage of endometrial cancer comprises epidemiological estimates of key patient populations in the emerging pharmaceutical markets (Australia, Hong Kong, Indonesia, Malaysia…
DRG Epidemiology’s coverage of endometrial cancer comprises epidemiological estimates of key patient populations in Europe (Austria, Belgium, Czech Republic, Denmark, Finland, Greece, the…
DRG Epidemiology’s coverage of endometrial cancer comprises epidemiological estimates of key patient populations in the emerging pharmaceutical markets (Argentina, Canada, Chile, Colombia, and…
DRG Epidemiology’s coverage of endometrial cancer comprises epidemiological estimates of key patient populations in the emerging pharmaceutical markets (Brazil, China, India, Mexico, Russia,…
The highly genericized biguanides and sulfonylureas are, by far, the most heavily prescribed type 2 diabetes (T2D) drug classes. However, branded agents from several drug classes are jostling for…